| 2021-12-21 |
|
|
|
External link to document |
| 2021-12-21 |
114 |
Order - Memorandum and Order AND ~Util - Terminate Motions |
U.S. Patent No. 9,439,906 (“the ’906 patent”) against Tolmar in this
action. The ’906 patent is generally…loading dose.
’906 patent, cl. 1.
On its face, the ’906 patent claims priority to one …applicant for a patent.” Accordingly,
the key question is whether the claims of the ’906 patent are entitled…AND ORDER
In this Hatch-Waxman Act patent case, plaintiffs Janssen Pharmaceuticals Inc. and…dispute the priority date of the claims of the ’906 patent. For purposes of the present motion, claim
|
External link to document |
| 2021-12-21 |
124 |
In Limine |
proceedings regarding U.S.
Patent No. 9,439,906 (“the ‘906 patent”), including but not limited to…proceedings
regarding [U.S. Patent No. 9,439,906] (the “906 Patent”).” Tolmar’s Motion in Limine to…Other Litigation Proceedings Regarding U.S. Patent No. 9,439,906 - filed by Tolmar, Inc.. (Poff, Adam) (Entered… PROCEEDINGS REGARDING U.S. PATENT NO. 9,439,906
Case 1:21-cv-01784-WCB-SRF Document 124 …
PROCEEDINGS REGARDING U.S. PATENT NO. 9,439,906
|
External link to document |
| 2021-12-21 |
125 |
Exhibit to a Document |
Other Litigation Proceedings Regarding U.S. Patent No. 9,439,906 by Tolmar, Inc.. (Attachments: # 1 Declaration…2021
13 March 2024
1:21-cv-01784
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
| 2021-12-21 |
127 |
Redacted Document |
of U.S. Patent No. 9,439,906 (the
“’906 Patent” or the “Patent-in-Suit”). The ’906 Patent claims, …Order
Regarding Infringement of U.S. Patent No. 9,439,906, which the court so ordered on February … c) any legible U.S. or foreign patent, patent application, patent office publication, or file
…infringement of the 906 Patent, prior to the expiration
of the 906 Patent, or such later date as the…. This is an action brought pursuant to the patent laws of the United States, Title 35,
Section |
External link to document |
| 2021-12-21 |
137 |
Statement |
Janssen’s U.S. Patent No. 9,439,906 (the “’906
patent”) (JTX-1). The ’906 patent is directed to…INVENTIONS OF THE ’906 PATENT
The dosing regimens claimed in the ’906 patent recite a specific …3176
that issued as U.S. Patent No. 6,555,544, the “’544 patent” (one of the references Tolmar’…the ’544 patent are described
as effective for three weeks to a month, and the ’544 patent taught that… of claims 17-21 of the ’906 patent are not obvious. The ’544
patent disclosed an upper limit to a |
External link to document |
